Document:

<PAGE>
                                                                   EXHIBIT 10.23

                    AMENDED AND RESTATED EMPLOYMENT AGREEMENT

                  Made and entered into in on January 1st, 2006

Between:           OMRIX BIOPHARMACEUTICALS LTD.
                   Building 14, Kiryat Weizman
                   Rehovot, Israel
                   (hereinafter:  the "COMPANY")

                                                    ON THE ONE PART

and:
                   MICHAEL BURSHTINE, I.D. No. 058717687
                   Residing at 14 Finstein Street Tel Aviv, Israel
(hereinafter the "EMPLOYEE")
                                                    ON THE SECOND PART

WHEREAS     the Employee and the Company have entered into an Employment
            Agreement dated February 8, 2004 (the "EMPLOYMENT AGREEMENT");

WHEREAS,    the Employee continues to be employed with the Company;

WHEREAS,    the Employee and the Company wish to amend and restate the
            Employment Agreement effective as of January 1st , 2006 (the
            "AMENDMENT DATE");

1.   HEADINGS

     The headings of the sections in this Agreement are for convenience only and
     shall not be used for the purpose of interpretation of this Agreement.

2.   DEFINITIONS

     Capitalized terms and expressions shall have the meaning indicated next to
     each one of them:

     "EFFECTIVE DATE" - means the first date of employment of the Employee by
     the Company, being April 18, 2004.

     "TERM" - has the meaning ascribed to it in Section 11.1 below.

     "OMRIX GROUP" - shall mean Omrix Biopharmaceuticals Inc. (the "PARENT"),
     and all of its subsidiaries, including Omrix Biopharmaceuticals S.A., the
     Company and Biopex Ltd.

THE EMPLOYMENT

     2.1. During the Term (as defined below), the Employee shall serve as Senior
          Vice President and Chief Financial Officer ("CFO") of the Omrix Group
          (hereinafter The "POSITION"). The Employee hereby undertakes to devote
          his full-time attention and energies and use his best efforts in his
          employment with the Company and for the Omrix Group.The official
          employer of the Employee shall be the Company.

     2.2. During the Term, the Employee's duties and responsibilities shall be
          as provided in Section 3 hereof and shall include those duties and
          responsibilities customarily performed by a CFO or as may be assigned
          to the Employee from time to time by the Company's Chief Executive
          Officer (the "CEO").

<PAGE>

     2.3. The working place of the Employee is Israel. However, the Employee
          recognizes that the Position require extensive travel to the office of
          the CEO in Belgium and possibly, subject to a formal request by the
          Company a relocation to Belgium or to the USA for several years. The
          financial terms in case of a request for relocation will be agreed
          between the parties separately.

     2.4. The Employee shall be reporting to the CEO.

     2.5. The Employee hereby represents that, to the best of his knowledge,
          there is no hindrance, whether by law, by Agreement, or in any other
          way, to his employment by any member of the Omrix Group in the
          Position and on terms stated herein. The Employee agrees that, in the
          event the Employee breaches this representation under this
          Sub-Section, he will indemnify and hold harmless the Omrix Group from
          and against any claims, losses, damages and expenses arising out of
          such breach.

3.   THE EMPLOYEE'S DUTIES

     3.1. The Employee undertakes to fulfill his Position diligently, devotedly,
          expertly and honestly, and to use all his abilities, knowledge,
          experience and expertise for the benefit of the Omrix Group and to do
          his utmost to further the business interest of the Omrix Group and to
          devote all the time reasonably required for this purpose.

     3.2. The Employee undertakes to perform his obligations hereunder in
          accordance with the Omrix Group's corporate ethics, principles and
          rules. The management of the Company shall always be carried out in
          conformity with the procedures, practices, policies and the objectives
          of the Company as determined and manifested by its Board of Directors.

     3.3. Throughout the Term, without the consent of any member of the Omrix
          Group, the Employee will not be entitled to engage, directly or
          indirectly, in any other work or occupation without the prior approval
          of the CEO, irrespective of whether or not the Employee is remunerated
          for such work and/or services and/or engagement.

     3.4. The Employee undertakes to inform the CEO without delay of any
          business and/or matter in which he has a personal interest and which,
          to the Employee's best judgment, may cause a conflict of interest with
          the Position.

4.   PERSONAL AGREEMENT

     4.1. This Agreement is personal and specific, defines the entire scope of
          relationship between the Employee and the Company and determines
          exclusively the terms under which the Employee is employed by the
          Company.

     4.2. In light of the above, the provisions of any collective bargaining
          agreement which exist or shall exist do not, and will not, apply to
          the employment of the Employee hereunder, whether such agreement was
          signed among the government, the General Federation of Labor and
          Employers' organizations, or any such parties, or whether signed by
          others, in relation to the field or fields of the Company or in
          relation to the kind of employees the Employee belongs to.

     4.3. It is agreed between the parties that the Position is a management
          position which requires a special measure of personal trust, as
          stipulated in section 30(a)(5)(6) of the WORKING HOURS AND REST LAW,
          1951. In light of such trust relations, the provisions of the said Law
          will not apply to the Employee's employment by the Company and the
          Employee shall not be entitled to demand or accept payment for
          overtime and that the salary specified in Section 6.1, will also
          include compensation and global payment for any and all hours which
          the Employee will spend while discharging his duties for the Company.

     4.4. Furthermore it is expressly agreed that the terms of the Employee's
          employment as stated herein will not be affected or altered by the
          terms of employment of any other employee of the Company or the Omrix
          Group and that the terms of the Employee's

                                       2
<PAGE>

          employment by the Company shall be determined exclusively by the law
          and/or the provisions of this Agreement and/or according to any
          changes, if any, of the law, and/or by mutual agreement of the
          parties.

5.   SALARY AND TERMS OF EMPLOYMENT

     During the Term, the Company will pay the Employee in return for his work
     and for the execution of this Agreement, the following salary and other
     payments and benefits as follows:

     5.1. Salary

          5.1.1.    A gross monthly salary of US$12,500 to be paid in US
                    dollars. Each monthly salary will be paid not later than by
                    the 9th day of each calendar month for the previous month
                    work (hereinafter "THE BASIC SALARY").

          5.1.2.    The Basic Salary as indicated above is before taxes (gross)
                    and includes payments in full for overtime, including the
                    time spent abroad.

          5.1.3.    The Employee agrees that he is not entitled to any social
                    benefits and fringe benefits other than those listed herein,
                    as compensation or salary in excess of the Basic Salary.

     5.2. Employee Benefits

          The Employee shall be entitled to the following benefits:

          5.2.1.    Personal Car: The Company shall place at the Employee's
                    disposal, for his and his immediate family exclusive use, a
                    company car (at the standard of Omrix Group executive
                    management), in order to enable the performance of the
                    Employee's duties and responsibilities. The above car shall
                    remain at the Employee's disposal at any time, including
                    during vacation. The Company shall pay and/or reimburse the
                    Employee for tax, gasoline, maintenance and parking expenses
                    in relation to the said car. The Employee will not be
                    entitled to a refund for expenses due to traffic tickets.

          5.2.2.    Vacation: The Employee shall be entitled to an annual
                    vacation of 22 (thirty) working days. Up to 50 (fifty)
                    vacation days may be accumulated.

          5.2.3.    Sick Leave: The Employee shall be entitled to up to 30
                    (thirty) days fully paid Sick Leave a year. The Employee
                    shall not be entitled to accumulate Sick Leave days beyond a
                    period of 6 (six) months. The unused Sick Leave days shall
                    not be redeemable. Notwithstanding the above, the Employee
                    shall not be entitled to receive a portion of the Basic
                    Salary during Sick Leave in the event that he shall receive
                    equivalent payments from an insurance company in accordance
                    with the provisions of Section 6.2.5.

          5.2.4.    Recreation Payment: The Employee shall be entitled to
                    Recreation Payment for 10 (ten) days, to be paid at the end
                    of each work year, in the amount required by law.

          5.2.5.    Managers' Insurance Policy: The Company shall effect a
                    Managers' Insurance Policy, or maintain the Employee's
                    Managers' Insurance Policy, as shall be directed by the
                    Employee in its sole discretion (hereinafter: the "POLICY")
                    in the name of the Employee and shall pay a sum which equals
                    to 18.83% of the Employee's Basic Salary towards such
                    Policy, of which 8.33% will be on account of severance pay
                    and 5% on account of pension fund payments. The Company
                    shall deduct 5% from the Employee's Basic Salary to be paid
                    on behalf of the Employee towards such Policy. An additional
                    amount which equals to 2.5% of the

                                       3
<PAGE>

                    Employee's Basic Salary shall be paid by the Company on
                    account of the Employee's disability pension payments.

          5.2.6.    Continued Educational Fund (CED): The Company shall pay in
                    respect of the Employee, each month, an amount equals to
                    7.5% of his gross Salary, into a Continued Educational Fund
                    approved as such by the Tax Authorities. The Employee shall
                    pay each month to the above Fund an amount equivalent to
                    2.5% of his gross Salary.

          5.2.7.    Mobile Phone: During the term of this Agreement, the Company
                    shall reimburse the Employee for all his mobile phone
                    expenses.

          5.2.8.    Bonus:

                    With respect to the period up to the Amendment Date, the
                    Employee shall be entitled to receive the bonuses as per the
                    wording of the Employment Agreement prior to this Amendment
                    which is made on the Amendment Date.

                    Starting from the Amendment Date, each year the Employee
                    will be entitled to receive a the following bonus on an
                    annual basis: (a) an unconditional minimum amount of
                    US$30,000 (the "BASE BONUS"); and (b) a discretionary
                    additional amount of up to 36% of the Employee's aggregate
                    annual Basic Salary (the criteria for evaluation of such
                    additional bonus entitlement under sub section (b) will be
                    based 50% on evaluation of the Employee's performance of its
                    duties hereunder and 50% on the performance of the Omrix
                    Group (the "PERFORMANCE BONUS"). The Base Bonus and
                    Performance Bonus will not carry any social benefits. The
                    Base Bonus will be paid in four equable quarterly
                    installments.

          5.2.9.    Telephone: The Company will cover the cost of the private
                    home telephone line of the Employee.

6.   NON-COMPETITION

     6.1. Without prejudice to any of the Employee's other undertakings in
          respect of applicable unfair competition regulations, it is agreed
          that during the Term and during a period of two (2) years after its
          termination, for any reason, the Employee shall not directly or
          indirectly, individually for his own account or as an employee,
          shareholders, partner, consultant of any firm, partnership,
          corporation or other entity or in any other capacity whatsoever be
          involved in the business of plasma fractionation and/or plasma
          derivative products including but not limited to biological surgical
          or fibrin adhesives, in the world.

     6.2. During the Term, and for a period of two (2) years after its
          termination, for any reason, the Employee shall not, directly of
          indirectly, either on his own behalf or on behalf of any other person,
          firm, corporation or other entity, without prior written consent of
          the Company:

          (a)   Attempt in any manner to persuade any client of the Company
                and/or the Omrix Group to cease to do business or to reduce the
                amount of business which any client has customarily done or
                contemplates doing with any of the Company and/or the Omrix
                Group, whether or not the relationship between the Omrix Group
                and such client was originally established, in whole or in part,
                through the Employee's efforts; and/or

          (b)   Employ or attempt to employ any person who is then in the employ
                of any of the Company and/or the Omrix Group or was in the
                employ of any of the Company and/or the Omrix Group within six
                (6) months prior to the Employee's termination of employment;
                and

                                       4
<PAGE>

          (c)   Solicit business of any client of the Company and/or the Omrix
                Group unless such solicitation is for the benefit of the
                Company and/or the Omrix Group, or render any services of the
                type usually rendered by the Company and/or the Omrix Group to
                any such client of the Company and/or the Omrix Group unless
                such services are rendered for the benefit or on behalf of the
                Company and/or the Omrix Group or unless such services are
                without breach of the Employee's obligations under Section 6.1
                above.

7.   NON DISCLOSURE OF INFORMATION

     7.1. The Employee shall not at any time, during the term of this Agreement
          or thereafter, use for his own account or for the account of any third
          party any of the clients lists, trade secrets or other proprietary
          information or any trade name, trademark, service mark or other
          proprietary business designation used or owned by the Company and/or
          by the Omrix Group.

     7.2. During the term of this Agreement and thereafter, the Employee may
          receive or have access to Company's and/or Omrix Group's confidential,
          proprietary information or documents not in the public domain and to
          confidential or proprietary information of any clients of the Company
          and/or of the Omrix Group. The Employee agrees to receive such
          information in confidence and not to disclose at any time, or use
          (except in the course of his employment hereunder and in furtherance
          of the business of the Company and/or the Omrix Group), during the
          term of this Agreement or thereafter, such information without the
          express written consent of the Company (given by the CEO) or of the
          Omrix Group, as the case may be. Without limiting the foregoing, the
          Employee shall not, during the term of his employment, or at any time
          thereafter, copy or reproduce for the Employee's use or give, divulge,
          reveal or otherwise disclose to any person, corporation, partnership
          or other business or professional entity, except as authorized to do
          so by the Company's CEO, any form, document, written material or
          computer program, or any method, formula, plan, advertisements or
          advertising campaigns or plans created, developed or utilized by the
          Companies and/or by the Omrix Group or by the Employee as an employee
          of the Company for the purpose of rendering services, programs or
          other products and materials to the clients of the Company and/or of
          the Omrix Group, nor will the Employee copy or reproduce for the
          Employee's use or give, divulge, reveal or otherwise disclose to any
          person, corporation, partnership or other business or professional
          entity, except as authorized to do so by the CEO, any confidential
          business information of any client of the Company or the Omrix Group.

8.   TAXES

     8.1. Unless otherwise specifically indicated in this Agreement, the Company
          shall not pay any tax or other obligatory payments such as Income Tax,
          Social Security or Health Tax which the Employee is obliged to pay by
          law.

     8.2. The Company shall deduct from any payment or fringe benefit to which
          the Employee shall be entitled in accordance with this Agreement,
          taxes and other obligatory payments as required by law, and shall
          transfer to the proper authorities any and all such taxes, deductions
          and allocations.

9.   HAND OVER TO SUCCESSOR

     Upon termination of the Employee's employment by the Company for whatever
     reason, the Employee shall hand over, in an orderly manner, to his
     successor or to any other person of the Company's choice, all the
     information and documentation in his possession. Without derogating from
     the above the Employee shall, upon the Company's written request,
     immediately hand over to the Company any and all documents, information and
     any other material in his possession which belongs to the Company and/or
     the Omrix Group and/or any of their clients, including documentation which
     was prepared by the Employee during the course of his employment.

                                       5
<PAGE>

10.  INTELLECTUAL PROPERTY RIGHTS

     10.1. The Employee shall notify the Company in writing of any copyright,
           patent, invention, improvement of process or design in his possession
           developed and/or obtained by him during the Term and shall hand over
           any such rights and documents exclusively to the Company.

     10.2. Any title and/or right to any invention, development, copyright,
           parent, improvement of process or design developed by the Employee
           during the Term shall belong exclusively to the Company and the
           Employee hereby waives any right therein.

     10.3. The Employee shall sign, if requested by the Company to do so, any
           document required in order to file, in the name of the Company, an
           application for patent, copyright, trademark, registered design etc.,
           in respect of any invention, patent, improvement of process, design,
           text, etc., developed/invented by the Employee during the Term.

     10.4. The Employee shall take whatever reasonable steps shall be necessary
           in order to protect and maintain intact the Company's business and
           interests.

11.  TERM AND TERMINATION

     11.1. This Agreement shall come into effect on the Effective Date and shall
           terminate not sooner than April 18, 2007 (the "ANNIVERSARY DATE") and
           will, on the Anniversary Date and on each anniversary of the
           Anniversary Date thereafter, automatically renew for an additional
           period of one (1) year period, unless a notice of intent not to renew
           shall be delivered in accordance with this Section 11 by either the
           Company or the Employee, each in its sole discretion and as the case
           may be, at least six (6) months prior to such anniversary date (the
           "TERM").

     11.2. Notwithstanding Sub-Section 11.1, the Company shall be entitled to
           dismiss the Employee and to terminate his employment forthwith (with
           immediate effect) in the event of Cause or Disability.

           11.2.1.  CAUSE - shall mean that (a) the Employee acts contrary to
                    the instructions of the CEO of the Company or materially
                    exceeds the limits of his authority as described herein or
                    in written instructions executed by the CEO; provided that
                    such action or omission form action is not a result of a
                    requirement of a court order or applicable law; or (b) the
                    Employee behaves in a manner which materially deviates from
                    the very high standards of integrity expected from a Senior
                    Executive; or (c) the Employee is charged with a criminal
                    offence other than traffic violation, or (d) the Employee is
                    in a material breach of its obligations under Section 7
                    hereof; or (e)the Employee is in a material breach of its
                    obligations under Section 6 hereof; or (f) the Employee is
                    in a material breach of its obligations under Section 3
                    hereof; or (g) the Employee fraudulently reports falsely or
                    inaccurately about his activities and/or about the business
                    of the Company and/or the Omrix Group; or (h) the Employee
                    makes fraudulent representations toward third parties as to
                    the policy of any member of the Omrix Group or the
                    services/products provided/rendered by it.

           11.2.2.  DISABILITY - shall mean a physical or mental incapacity
                    lasting for a period of not less than (a) sixty (60) days in
                    any twelve (12) month period which renders the Employee
                    unable to perform his responsibilities and duties under this
                    Agreement.

     11.3. Upon termination for Cause, the Employee will receive his basic
           Salary and other compensation and benefits earned under this
           Agreement but not yet paid or delivered as of the date of termination
           of this Agreement but will not be entitled to severance pay, the
           right to receive the Company contribution to the Policy or to any
           other compensation from the Company.

                                       6
<PAGE>

     11.4. Upon termination of the Employee's employment with the Company, by
           the Company other than termination for Cause, the Employee shall be
           entitled to (a) his Basic Salary payable through the Anniversary
           Date or the respective anniversary of the Anniversary Date, as the
           case nay be (in each case, the "TERMINATION PERIOD") as if the
           Employee were to be employed for such Termination Period, plus (b) a
           pro rata portion of the Base Bonus and Performance Bonus for the
           Termination Period, plus (e) any and all other accrued compensation
           and benefits earned under this Agreement but not yet paid or
           delivered to the Employee as of the date of the termination of the
           Agreement, including the use of the car and payment of expenses
           during the Termination Period, severance pay required by law and the
           right to receive the Policy shall be automatically assigned to the
           Employee.

     11.5. It is hereby agreed that in the event that the Company transfers the
           ownership of the Policy or any other insurance policy or the right
           to receive such policy to the Employee, then the 8.33% paid by the
           Company on account of severance pay and included in such transfer
           shall be credited against any obligation that the Company may have
           to pay severance pay to the Employee pursuant to the Severance Pay
           Law, 1963.

12.  CONTINUOUS EMPLOYMENT; SURVIVAL OF PROVISIONS.

     It is hereby acknowledged and clarified that the employment of the Employee
     by the Company has commenced on the Effective Date and the Employee shall
     continue to be employed by the Company on a continuous ongoing basis until
     the termination of this Agreement pursuant to its terms. It is further
     clarified that the amending and restating of the Employment Agreement
     hereunder shall not effect its validity and the Employment Agreement, as
     amended, shall remain in full force and effect with respect to the
     employment of the Employee.

13.  WAIVER SHALL NOT CONSTITUTE A PRECEDENT

     The failure of any party to enforce at any time any provision of this
     Agreement, or to enforce any rights, or to make any elections hereunder,
     shall not be deemed to be a waiver of such provisions, rights of elections.

14.  SEVERABILITY

     In case one or more of the provisions contained in this Agreement shall,
     for any reason, be held to be invalid, illegal or unenforceable in any
     respect, such invalidity, illegality or unenforceability shall not affect
     the other provisions of this Agreement, and this Agreement shall be
     construed as if such invalid, illegal or unenforceable provision had never
     been contained herein. If moreover, any one or more of the provisions
     contained in this Agreement shall for any reason be held to be excessively
     broad as to duration, geographical scope, activity or subject, it shall be
     construed by limiting and reducing it, so as to be enforceable to the
     extent compatible with the applicable law as it shall then appear.

15.  INVALIDITY OF PREVIOUS AGREEMENTS

     This Agreement represents the entire understanding and agreement between
     the parties hereto and supersedes all prior negotiations, representations
     and agreements made by and between the parties prior to this Agreement in
     connection with the Employee's employment by the Company, whether in
     writing, orally or in any other way.

16.  AMENDMENTS

                                       7
<PAGE>

     This Agreement may be amended only by a written document executed by all
     parties hereto and any amendment purportedly made in any other way shall
     not be binding on the parties hereto.

17.  NOTICES

     The addresses of the parties are as indicated in the preamble to this
     Agreement and any notice sent by one of the parties to the other party by
     registered mail to the above addresses shall be deemed to have been
     received by the addressee three (3) business days after being posted,
     postage pre-paid, and in the event of hand delivery - at the time of such
     delivery.

                                       8
<PAGE>

18.  LAW AND JURISDICTION

     This Agreement shall be governed by and construed in accordance with the
     laws of the State of Israel, and the competent Courts in Tel-Aviv-Jaffa
     will have the sole jurisdiction in any dispute arising hereunder.

     IN WITNESS WHEREOF the above parties have executed this Amended and
Restated Agreement on the date first hereinabove written.

     /s/ Robert Taub                   /s/ Michael Burshtine
------------------------------        ------------------------
OMRIX BIOPHARMACEUTICALS LTD.          MICHAEL BURSHTINE

                                       9<PAGE>
                                                                   Exhibit 10.24

                              CONSULTING AGREEMENT

     THIS CONSULTING AGREEMENT (the "Agreement"), made this first day of
October, 2002, is entered into by Omrix Biopharmaceuticals, Inc., a Delaware
corporation (the "Company"), and Bemsol SA, a Belgian corporation represented
by Philippe Romagnoli, with an address of 22, avenue des Pommiers at B-4053
Embourg (the "Consultant").

                                  INTRODUCTION

     The Company desires to retain the services of the Consultant and the
Consultant desires to perform certain services for the Company. In consideration
of the mutual covenants and promises contained herein and other good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged by the parties hereto, the parties agree as follows:

     1. Services. The Consultant agrees to perform such consulting, advisory and
related services to and for the Company as requested by the Company, and as
specified on Schedule A to this Agreement. During the Consultation Period (as
defined below), the Consultant shall not engage in any activity that has a
conflict of interest with the Company, including any directly competitive
employment, business, or other activity, and he shall not assist any other
person or organization that directly competes with the Company.

     2. Term. This Agreement shall commence on the date hereof and is concluded
for a period of one year (such period, as it may be extended, being referred to
as the "Consultation Period"), unless sooner terminated in accordance with the
provisions of Section 4.

     3. Compensation and Benefits.

          3.1 Compensation. In consideration for the consulting services
rendered by the Consultant the Consultant shall receive the compensation as
indicated on Exhibit A.

          3.2 Reimbursement of Expenses. The Company shall reimburse the
Consultant for all reasonable and necessary expenses incurred or paid by the
Consultant in connection with, or related to, the performance of his services
under this Agreement. The Consultant shall submit to the Company itemized
monthly statements of such expenses incurred in the previous month. The Company
shall pay to the Consultant amounts shown on each such statement within 30 days
after receipt thereof.

          3.3 Benefits. The Consultant shall not be entitled to any benefit
coverage or privilege, including, without limitation, social security,
unemployment, medical or pension payments, made available to employees of the
Company.

     4. Termination. At its expiration, the Consultation Period may be renewed
by mutual agreement for an additional period of one year. Conversely, this
agreement can be ended prior to its normal end if both parties agree so and
settle any compensation and/or prejudice pending. Notwithstanding the foregoing,
the Company may terminate the Consultation Period, effective immediately upon
receipt of written notice, if the Consultant breaches or threatens to breach any
provision of Section 6.

<PAGE>

     5. Cooperation. The Consultant shall use his best efforts in the
performance of his obligations under this Agreement. The Company shall provide
such access to its information and property as may be reasonably required in
order to permit the Consultant to perform his obligations hereunder. The
Consultant shall cooperate with the Company's personnel, shall not interfere
with the conduct of the Company's business and shall observe all existing rules,
regulations and security requirements of the Company concerning the safety of
persons and property.

     6. Inventions and Proprietary Information.

          6.1 Inventions.

               (a) All inventions, discoveries, computer programs, data,
technology, designs, innovations and improvements (whether or not patentable and
whether or not copyrightable) (Inventions") related to the business of the
Company, i.e. plasma products and surgical sealants, which are made, Conceived,
reduced to practice, created, written, designed or developed by the Consultant,
solely or jointly with others and whether during normal business hours or
otherwise, during the Consultation Period or thereafter if resulting or directly
derived from Proprietary Information (as defined below), shall be the sole
property of the Company. The Consultant hereby assigns to the Company all
Inventions and any and all related patents, copyrights, trademarks, trade names,
and other industrial and intellectual property rights and applications therefor,
in the United States and elsewhere and appoints any officer of the Company as
his duly authorized attorney to execute, file, prosecute and protect the same
before any government agency, court or authority. Upon the request of the
Company and at the Company's expense, the Consultant shall execute such further
assignments, documents and other instruments as may be necessary or desirable to
fully and completely assign all Inventions to the Company and to assist the
Company in applying for, obtaining and enforcing patents or copyrights or other
rights in the United States and in any foreign country with respect to any
Invention. The Consultant also hereby waives all claims to moral rights in any
Inventions.

               (b) The Consultant shall promptly disclose to the Company all
Inventions and will maintain adequate and current written records (in the form
of notes, sketches, drawings and as may be specified by the Company) to document
the conception and/or fast actual reduction to practice of any Invention. Such
written records shall be available to and remain the sole property of the
Company at all times.

          6.2 Proprietary Information.

               (a) The Consultant acknowledges that his relationship with the
Company is one of high trust and confidence and that in the course of his
service to the Company he may have access to and contact with Proprietary
Information. The Consultant agrees that he will not during the Consultation
Period or at any time thereafter, disclose to others, or use for his benefit or
the benefit of others, any Proprietary Information or Invention.

               (b) For purposes of this Agreement, Proprietary Information shall
mean, by way of illustration and not limitation, all information (whether or not
patentable and whether or not copyrightable) owned, possessed or used by the
Company, including, without limitation, any Invention, formula, vendor
information, customer information, apparatus, equipment, trade secret, process,
research, report, technical data, know-how, computer program, software, software
documentation, hardware design, technology, marketing or business plan, forecast
unpublished financial statement, budget, license, price, cost and employee list
that is communicated to, learned of, developed or otherwise acquired by the
Consultant in the course of his service as a consultant to the Company.

<PAGE>

               (c) The Consultant's obligations under this Section 6.2 shall not
apply to any information that (i) is or becomes known to the general public
under circumstances involving no breach by the Consultant or others of the terms
of this Section 6.2, (ii) is generally disclosed to third parties by the Company
without restriction on such third parties, or (iii) is approved for release by
written authorization of the Board of Directors of the Company.

               (d) Upon termination of this Agreement or at any other time upon
request by the Company, the Consultant shall promptly deliver to the Company all
records, files, memoranda, notes, designs, data, reports, price lists, customer
lists, drawings, plans, computer programs, software, software documentation,
sketches, laboratory and research notebooks and other documents (and all copies
or reproductions of such materials) relating to the business of the Company.

               (e) The Consultant represents that his retention as a consultant
with the Company and his performance under this Agreement does not, and shall
not, breach any agreement that obligates him to keep in confidence any trade
secrets or confidential or proprietary information of his or of any other party
or to refrain from competing, directly or indirectly, with the business of any
other party. The Consultant shall not disclose to the Company any trade secrets
or confidential or proprietary information of any other party.

               (f) The Consultant acknowledges that the Company from time to
time may have agreements with other persons or with the United States
Government, or agencies thereof, that impose obligations or restrictions on the
Company regarding inventions made during the course of work under such
agreements or regarding the confidential nature of such work. The Consultant
agrees to be bound by all such obligations and restrictions that are known to
him.

          6.3 Remedies. The Consultant acknowledges that any breach of the
provisions of this Section 6 shall result in serious and irreparable injury to
the Company for which the Company cannot be adequately compensated by monetary
damages alone. The Consultant agrees, therefore, that, in addition to any other
remedy it may have, the Company shall be entitled to enforce the specific
performance of this Agreement by the Consultant and to seek both temporary and
permanent injunctive relief (to the extent permitted by law) without the
necessity of proving actual damages.

     7.1 Independent Contractor Status. The Consultant shall perform all
services under this Agreement as an "independent contractor" and not as an
employee or agent of the Company. The Consultant is not authorized to assume or
create any obligation or responsibility, express or implied, on behalf of, or in
the name of, the Company or to bind the Company in any manner.

     7.2 Consent to use of Name. The Consultant hereby consents to the use of
his name by the Company, as required, in connection with any business plan or
marketing materials prepared for use by the Company and any registration
statement, prospectus or other document filed with the United States Securities
and Exchange Commission, the National Association of Securities Dealers, Inc.
and the Nasdaq Stock Market.

     8. Notices. All notices required or permitted under this Agreement shall be
in writing and shall be deemed effective upon personal delivery or upon postal
deposit by registered or certified mail, postage prepaid, addressed to the other
party at the address shown above, or at such other address or addresses as
either party shall designate to the other in accordance with this Section 8.

     9. Pronouns. Whenever the context may require, any pronouns used in this
Agreement shall include the corresponding masculine, feminine or neuter forms,
and the singular forms of nouns and pronouns shall include the plural, and vice
versa.

<PAGE>

     10. Entire Agreement. This Agreement constitutes the entire agreement
between the parties and supersedes all prior agreements and understandings,
whether written or oral, relating to the subject matter of this Agreement.

     11. Amendment. This Agreement may be amended or modified only by a written
instrument executed by both the Company and the Consultant.

     12. Governing Law. This Agreement shall be construed, interpreted and
enforced in accordance with the laws of the State of Delaware.

     13. Successors and Assigns. This Agreement shall be binding upon, and inure
to the benefit of, both parties and their respective successors and assigns,
including any corporation with which, or into which, the Company may be merged
or which may succeed to its assets or business, provided, however, that the
obligations of the Consultant are personal and shall not be assigned by him.

     14. Miscellaneous.

          14.1 No delay or omission by the Company in exercising any right under
this Agreement shall operate as a waiver of that or any other right. A waiver or
consent given by the Company on any one occasion shall be effective only in that
instance and shall not be construed as a bar or waiver of any right on any other
occasion.

          14.2 The captions of the sections of this Agreement are for
convenience of reference only and in no way define, limit or affect the scope or
substance of any section of this Agreement.

          14.3 In the event that any provision of this Agreement shall be
invalid, illegal or otherwise unenforceable, the validity, legality and
enforceability of the remaining provisions shall in no way be affected or
impaired thereby.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year set forth above.

                                        Omrix Biopharmaceuticals, INC.

                                        By: /s/ Robert Taub
                                            ------------------------------------
                                            Robert Taub
                                        Title: Chief Executive Officer

                                        Bemsol SA

                                        By: /s/ Philippe Romagnoli
                                            ------------------------------------
                                            Philippe Romagnoli
                                        Title: Managing Director

<PAGE>

                                   SCHEDULE A

                            Services and Compensation

I.   Services

     a)   Meetings/Phone Calls with Company Management, mostly Robert Taub and
          John Barberich

     b)   Meetings/Phone Calls with industry contacts, if requested by
          Management and determined appropriate by Consultant

     c)   Review and Comments on Drafts of Company Materials, Sections of
          Business Plans, etc.

     d)   The service time is set to 60% of a standard full time schedule.

II.  Compensation

     a)   Euro 22.500 Consulting fee per quarter

     b)   If services are performed in excess of 60% of a standard full time
          schedule at the mutual agreement of the parties, Consultant will
          receive additional cash consulting fees equal to Euro 700 per day.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]